4//SEC Filing
Mead Johnson Nutrition Co 4
Accession 0001209191-17-016293
CIK 0001452575operating
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 11:17 AM ET
Size
22.5 KB
Accession
0001209191-17-016293
Insider Transaction Report
Form 4
Hondmann Dirk
SVP & Global Research & Dev
Transactions
- Award
Performance Shares
2017-02-28+1,323→ 1,323 total→ Common Stock (1,323 underlying) - Tax Payment
Common Stock
2017-02-28$87.79/sh−804$70,583→ 3,515 total - Exercise/Conversion
Common Stock
2017-02-28+2,582→ 4,319 total - Award
Restricted Stock Unit (RSU)
2017-02-28+6,584→ 6,584 totalFrom: 2020-02-28Exp: 2020-02-28→ Common Stock (6,584 underlying) - Exercise/Conversion
Performance Shares
2017-02-28−2,582→ 0 totalFrom: 2017-02-28Exp: 2017-02-28→ Common Stock (2,582 underlying) - Award
Restricted Stock Unit (RSU)
2017-02-28+4,389→ 4,389 totalExp: 2020-02-28→ Common Stock (4,389 underlying) - Award
Performance Shares
2017-02-28+1,024→ 2,582 totalFrom: 2017-02-28Exp: 2017-02-28→ Common Stock (1,024 underlying) - Award
Performance Shares
2017-02-28+817→ 817 total→ Common Stock (817 underlying)
Holdings
- 17,487(indirect: By Trust)
Common Stock
Footnotes (10)
- [F1]Represents shares of common stock withheld for payment of taxes upon the vesting of performance shares.
- [F10]Each performance share will convert into one share of common stock upon vesting and settlement in the first quarter of 2019.
- [F2]Each restricted stock unit represents the contingent right to receive one share of common stock.
- [F3]One-third of the restricted stock unit award will vest on each of the first, second and third anniversaries of the grant date.
- [F4]The derivative securities were granted to the reporting person, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for the derivative securities.
- [F5]Represents the current tranche of performance shares earned under the 2014 - 2016 performance share award as of February 28, 2017, at which date the Compensation and Management Development Committee certified the extent to which the 2016 performance criteria were met. Each earned performance share represents the contingent right to receive one share of common stock.
- [F6]Each performance share represents the contingent right to receive one share of common stock. This transaction represents the settlement of vested performance shares in shares of common stock.
- [F7]Represents the current tranche of performance shares earned under the 2015 - 2017 performance share award as of February 28, 2017, at which date the Compensation and Management Development Committee certified the extent to which the 2016 performance criteria were met. Each earned performance share represents the contingent right to receive one share of common stock.
- [F8]Each performance share will convert into one share of common stock upon vesting and settlement in the first quarter of 2018.
- [F9]Represents the current tranche of performance shares earned under the 2016 - 2018 performance share award as of February 28, 2017, at which date the Compensation and Management Development Committee certified the extent to which the 2016 performance criteria were met. Each earned performance share represents the contingent right to receive one share of common stock.
Documents
Issuer
Mead Johnson Nutrition Co
CIK 0001452575
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001452575
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 11:17 AM ET
- Size
- 22.5 KB